Patients with cirrhosis: low or very low ceruloplasmin (<5 mg/dL); increased 24-h urinary copper excretion (>100 μg/24 h); increased non-ceruloplasmin-bound copper; increased hepatic copper levels (>250 μg/g); thrombocytopenia; increased international normalized ratio. This evidence concerns the gene CP and Cirrhosis.